nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Temozolomide—malignant glioma	0.22	1	CbGbCtD
Darifenacin—Accidental injury—Carmustine—malignant glioma	0.0133	0.0248	CcSEcCtD
Darifenacin—Thinking abnormal—Carmustine—malignant glioma	0.0128	0.024	CcSEcCtD
Darifenacin—Vaginal inflammation—Temozolomide—malignant glioma	0.0114	0.0212	CcSEcCtD
Darifenacin—Vaginal infection—Temozolomide—malignant glioma	0.0107	0.02	CcSEcCtD
Darifenacin—Dry eye—Temozolomide—malignant glioma	0.0105	0.0196	CcSEcCtD
Darifenacin—Abnormal vision—Carmustine—malignant glioma	0.0102	0.0192	CcSEcCtD
Darifenacin—Mental disability—Carmustine—malignant glioma	0.0102	0.0191	CcSEcCtD
Darifenacin—Abnormal vision—Temozolomide—malignant glioma	0.0099	0.0185	CcSEcCtD
Darifenacin—Mental disability—Temozolomide—malignant glioma	0.00985	0.0184	CcSEcCtD
Darifenacin—Injury—Carmustine—malignant glioma	0.00928	0.0173	CcSEcCtD
Darifenacin—Face oedema—Carmustine—malignant glioma	0.00823	0.0154	CcSEcCtD
Darifenacin—Face oedema—Temozolomide—malignant glioma	0.00796	0.0149	CcSEcCtD
Darifenacin—Dry skin—Temozolomide—malignant glioma	0.00755	0.0141	CcSEcCtD
Darifenacin—Breast disorder—Temozolomide—malignant glioma	0.00745	0.0139	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00742	0.0139	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00727	0.0136	CcSEcCtD
Darifenacin—Bronchitis—Temozolomide—malignant glioma	0.00685	0.0128	CcSEcCtD
Darifenacin—Erectile dysfunction—Temozolomide—malignant glioma	0.00656	0.0123	CcSEcCtD
Darifenacin—Weight increased—Temozolomide—malignant glioma	0.00648	0.0121	CcSEcCtD
Darifenacin—Stomatitis—Carmustine—malignant glioma	0.00641	0.012	CcSEcCtD
Darifenacin—Urinary tract infection—Carmustine—malignant glioma	0.00639	0.0119	CcSEcCtD
Darifenacin—Infestation NOS—Temozolomide—malignant glioma	0.00635	0.0119	CcSEcCtD
Darifenacin—Infestation—Temozolomide—malignant glioma	0.00635	0.0119	CcSEcCtD
Darifenacin—Stomatitis—Temozolomide—malignant glioma	0.00619	0.0116	CcSEcCtD
Darifenacin—Urinary tract infection—Temozolomide—malignant glioma	0.00617	0.0115	CcSEcCtD
Darifenacin—Sinusitis—Temozolomide—malignant glioma	0.00596	0.0111	CcSEcCtD
Darifenacin—Hallucination—Carmustine—malignant glioma	0.00587	0.011	CcSEcCtD
Darifenacin—Oedema peripheral—Carmustine—malignant glioma	0.00581	0.0109	CcSEcCtD
Darifenacin—Visual impairment—Carmustine—malignant glioma	0.00569	0.0106	CcSEcCtD
Darifenacin—Hallucination—Temozolomide—malignant glioma	0.00567	0.0106	CcSEcCtD
Darifenacin—Pharyngitis—Temozolomide—malignant glioma	0.00566	0.0106	CcSEcCtD
Darifenacin—Urinary tract disorder—Temozolomide—malignant glioma	0.00563	0.0105	CcSEcCtD
Darifenacin—Oedema peripheral—Temozolomide—malignant glioma	0.00562	0.0105	CcSEcCtD
Darifenacin—Urethral disorder—Temozolomide—malignant glioma	0.00559	0.0104	CcSEcCtD
Darifenacin—Eye disorder—Carmustine—malignant glioma	0.00551	0.0103	CcSEcCtD
Darifenacin—Visual impairment—Temozolomide—malignant glioma	0.00549	0.0103	CcSEcCtD
Darifenacin—Erythema multiforme—Temozolomide—malignant glioma	0.00539	0.0101	CcSEcCtD
Darifenacin—Eye disorder—Temozolomide—malignant glioma	0.00533	0.00996	CcSEcCtD
Darifenacin—Angiopathy—Temozolomide—malignant glioma	0.00517	0.00967	CcSEcCtD
Darifenacin—Mental disorder—Carmustine—malignant glioma	0.00517	0.00966	CcSEcCtD
Darifenacin—Mediastinal disorder—Temozolomide—malignant glioma	0.00514	0.00961	CcSEcCtD
Darifenacin—Mental disorder—Temozolomide—malignant glioma	0.00499	0.00934	CcSEcCtD
Darifenacin—Back pain—Carmustine—malignant glioma	0.00497	0.00929	CcSEcCtD
Darifenacin—Dysgeusia—Temozolomide—malignant glioma	0.00486	0.00909	CcSEcCtD
Darifenacin—Vision blurred—Carmustine—malignant glioma	0.00484	0.00905	CcSEcCtD
Darifenacin—Back pain—Temozolomide—malignant glioma	0.0048	0.00897	CcSEcCtD
Darifenacin—Vision blurred—Temozolomide—malignant glioma	0.00468	0.00874	CcSEcCtD
Darifenacin—Angioedema—Temozolomide—malignant glioma	0.00453	0.00848	CcSEcCtD
Darifenacin—Hypertension—Carmustine—malignant glioma	0.00443	0.00829	CcSEcCtD
Darifenacin—Palpitations—Temozolomide—malignant glioma	0.00439	0.0082	CcSEcCtD
Darifenacin—Clotrimazole—CYP2B6—malignant glioma	0.00438	0.313	CrCbGaD
Darifenacin—Cough—Temozolomide—malignant glioma	0.00433	0.0081	CcSEcCtD
Darifenacin—Hypertension—Temozolomide—malignant glioma	0.00428	0.00801	CcSEcCtD
Darifenacin—Confusional state—Carmustine—malignant glioma	0.00423	0.0079	CcSEcCtD
Darifenacin—Arthralgia—Temozolomide—malignant glioma	0.00423	0.0079	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0042	0.00784	CcSEcCtD
Darifenacin—Oedema—Carmustine—malignant glioma	0.00419	0.00784	CcSEcCtD
Darifenacin—Infection—Carmustine—malignant glioma	0.00416	0.00778	CcSEcCtD
Darifenacin—Dry mouth—Temozolomide—malignant glioma	0.00413	0.00773	CcSEcCtD
Darifenacin—Tachycardia—Carmustine—malignant glioma	0.00409	0.00765	CcSEcCtD
Darifenacin—Confusional state—Temozolomide—malignant glioma	0.00408	0.00763	CcSEcCtD
Darifenacin—Anaphylactic shock—Temozolomide—malignant glioma	0.00405	0.00757	CcSEcCtD
Darifenacin—Oedema—Temozolomide—malignant glioma	0.00405	0.00757	CcSEcCtD
Darifenacin—Infection—Temozolomide—malignant glioma	0.00402	0.00752	CcSEcCtD
Darifenacin—Nervous system disorder—Temozolomide—malignant glioma	0.00397	0.00743	CcSEcCtD
Darifenacin—Skin disorder—Temozolomide—malignant glioma	0.00393	0.00735	CcSEcCtD
Darifenacin—Hyperhidrosis—Temozolomide—malignant glioma	0.00392	0.00732	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00382	0.00714	CcSEcCtD
Darifenacin—Insomnia—Carmustine—malignant glioma	0.00379	0.00709	CcSEcCtD
Darifenacin—Dyspnoea—Carmustine—malignant glioma	0.00374	0.00699	CcSEcCtD
Darifenacin—Somnolence—Carmustine—malignant glioma	0.00373	0.00697	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00369	0.0069	CcSEcCtD
Darifenacin—Insomnia—Temozolomide—malignant glioma	0.00366	0.00685	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00362	0.00676	CcSEcCtD
Darifenacin—Dyspnoea—Temozolomide—malignant glioma	0.00361	0.00675	CcSEcCtD
Darifenacin—Loperamide—CYP2B6—malignant glioma	0.00361	0.257	CrCbGaD
Darifenacin—Somnolence—Temozolomide—malignant glioma	0.0036	0.00673	CcSEcCtD
Darifenacin—Pain—Carmustine—malignant glioma	0.00358	0.0067	CcSEcCtD
Darifenacin—Constipation—Carmustine—malignant glioma	0.00358	0.0067	CcSEcCtD
Darifenacin—Dyspepsia—Temozolomide—malignant glioma	0.00357	0.00667	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0035	0.00654	CcSEcCtD
Darifenacin—Pain—Temozolomide—malignant glioma	0.00346	0.00648	CcSEcCtD
Darifenacin—Constipation—Temozolomide—malignant glioma	0.00346	0.00648	CcSEcCtD
Darifenacin—Methadone—CYP2C18—malignant glioma	0.00346	0.247	CrCbGaD
Darifenacin—Feeling abnormal—Carmustine—malignant glioma	0.00345	0.00646	CcSEcCtD
Darifenacin—Gastrointestinal pain—Carmustine—malignant glioma	0.00343	0.00641	CcSEcCtD
Darifenacin—Feeling abnormal—Temozolomide—malignant glioma	0.00334	0.00624	CcSEcCtD
Darifenacin—Abdominal pain—Carmustine—malignant glioma	0.00331	0.00619	CcSEcCtD
Darifenacin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00331	0.00619	CcSEcCtD
Darifenacin—Abdominal pain—Temozolomide—malignant glioma	0.0032	0.00599	CcSEcCtD
Darifenacin—Hypersensitivity—Carmustine—malignant glioma	0.00309	0.00577	CcSEcCtD
Darifenacin—Asthenia—Carmustine—malignant glioma	0.00301	0.00562	CcSEcCtD
Darifenacin—Hypersensitivity—Temozolomide—malignant glioma	0.00298	0.00558	CcSEcCtD
Darifenacin—Asthenia—Temozolomide—malignant glioma	0.00291	0.00543	CcSEcCtD
Darifenacin—Diarrhoea—Carmustine—malignant glioma	0.00287	0.00536	CcSEcCtD
Darifenacin—Pruritus—Temozolomide—malignant glioma	0.00287	0.00536	CcSEcCtD
Darifenacin—Dizziness—Carmustine—malignant glioma	0.00277	0.00518	CcSEcCtD
Darifenacin—Diarrhoea—Temozolomide—malignant glioma	0.00277	0.00518	CcSEcCtD
Darifenacin—Dizziness—Temozolomide—malignant glioma	0.00268	0.00501	CcSEcCtD
Darifenacin—Vomiting—Carmustine—malignant glioma	0.00266	0.00498	CcSEcCtD
Darifenacin—Rash—Carmustine—malignant glioma	0.00264	0.00494	CcSEcCtD
Darifenacin—Dermatitis—Carmustine—malignant glioma	0.00264	0.00494	CcSEcCtD
Darifenacin—Headache—Carmustine—malignant glioma	0.00263	0.00491	CcSEcCtD
Darifenacin—Vomiting—Temozolomide—malignant glioma	0.00258	0.00481	CcSEcCtD
Darifenacin—Methadone—CYP2B6—malignant glioma	0.00257	0.183	CrCbGaD
Darifenacin—Rash—Temozolomide—malignant glioma	0.00255	0.00477	CcSEcCtD
Darifenacin—Dermatitis—Temozolomide—malignant glioma	0.00255	0.00477	CcSEcCtD
Darifenacin—Headache—Temozolomide—malignant glioma	0.00254	0.00474	CcSEcCtD
Darifenacin—Nausea—Carmustine—malignant glioma	0.00249	0.00465	CcSEcCtD
Darifenacin—Nausea—Temozolomide—malignant glioma	0.00241	0.0045	CcSEcCtD
Darifenacin—CHRM2—Signaling Pathways—PTK2—malignant glioma	6.36e-05	0.000275	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—AKT2—malignant glioma	6.34e-05	0.000274	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	6.33e-05	0.000274	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HES1—malignant glioma	6.33e-05	0.000274	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—EGFR—malignant glioma	6.32e-05	0.000273	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HES1—malignant glioma	6.31e-05	0.000273	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NCOR1—malignant glioma	6.29e-05	0.000272	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NCOR1—malignant glioma	6.27e-05	0.000271	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HES1—malignant glioma	6.25e-05	0.00027	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—BRAF—malignant glioma	6.24e-05	0.00027	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NCOR1—malignant glioma	6.21e-05	0.000269	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—RAF1—malignant glioma	6.21e-05	0.000268	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—RAF1—malignant glioma	6.19e-05	0.000268	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—BCHE—malignant glioma	6.14e-05	0.000265	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2—malignant glioma	6.13e-05	0.000265	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—RAF1—malignant glioma	6.13e-05	0.000265	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CAV1—malignant glioma	6.12e-05	0.000264	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2—malignant glioma	6.11e-05	0.000264	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CD—malignant glioma	6.09e-05	0.000263	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—AKT2—malignant glioma	6.07e-05	0.000262	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	6.06e-05	0.000262	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.06e-05	0.000262	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2—malignant glioma	6.05e-05	0.000262	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—EGFR—malignant glioma	6.05e-05	0.000261	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	6.04e-05	0.000261	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—PIK3CA—malignant glioma	6.04e-05	0.000261	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	6.03e-05	0.000261	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	6.01e-05	0.00026	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—IDH1—malignant glioma	6.01e-05	0.00026	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	5.98e-05	0.000259	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—KRAS—malignant glioma	5.97e-05	0.000258	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	5.95e-05	0.000257	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SPP1—malignant glioma	5.85e-05	0.000253	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CD—malignant glioma	5.84e-05	0.000252	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—FGF2—malignant glioma	5.83e-05	0.000252	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SPP1—malignant glioma	5.83e-05	0.000252	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	5.83e-05	0.000252	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SPHK1—malignant glioma	5.81e-05	0.000251	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	5.81e-05	0.000251	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—PIK3CA—malignant glioma	5.78e-05	0.00025	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SPP1—malignant glioma	5.78e-05	0.00025	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	5.75e-05	0.000249	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—KRAS—malignant glioma	5.71e-05	0.000247	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.69e-05	0.000246	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—FGF2—malignant glioma	5.59e-05	0.000241	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CG—malignant glioma	5.57e-05	0.000241	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2—malignant glioma	5.57e-05	0.000241	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2—malignant glioma	5.55e-05	0.00024	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TERT—malignant glioma	5.55e-05	0.00024	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TERT—malignant glioma	5.53e-05	0.000239	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2—malignant glioma	5.5e-05	0.000238	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PIK3CA—malignant glioma	5.48e-05	0.000237	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TERT—malignant glioma	5.48e-05	0.000237	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MDM2—malignant glioma	5.46e-05	0.000236	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RAF1—malignant glioma	5.44e-05	0.000235	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PDGFB—malignant glioma	5.41e-05	0.000234	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PDGFB—malignant glioma	5.4e-05	0.000233	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FGFR1—malignant glioma	5.39e-05	0.000233	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ERBB2—malignant glioma	5.38e-05	0.000233	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARG—malignant glioma	5.38e-05	0.000232	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FGFR1—malignant glioma	5.37e-05	0.000232	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PDGFB—malignant glioma	5.34e-05	0.000231	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FGFR1—malignant glioma	5.32e-05	0.00023	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CB—malignant glioma	5.31e-05	0.00023	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HIF1A—malignant glioma	5.31e-05	0.000229	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HIF1A—malignant glioma	5.29e-05	0.000229	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PIK3CA—malignant glioma	5.25e-05	0.000227	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HIF1A—malignant glioma	5.24e-05	0.000226	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MDM2—malignant glioma	5.23e-05	0.000226	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RAF1—malignant glioma	5.21e-05	0.000225	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ERBB2—malignant glioma	5.15e-05	0.000223	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CAV1—malignant glioma	5.13e-05	0.000222	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CAV1—malignant glioma	5.11e-05	0.000221	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL8—malignant glioma	5.1e-05	0.000221	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CB—malignant glioma	5.09e-05	0.00022	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KDR—malignant glioma	5.07e-05	0.000219	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CAV1—malignant glioma	5.07e-05	0.000219	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KDR—malignant glioma	5.06e-05	0.000219	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KDR—malignant glioma	5.01e-05	0.000216	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—AKT1—malignant glioma	4.93e-05	0.000213	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CD—malignant glioma	4.9e-05	0.000212	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL8—malignant glioma	4.89e-05	0.000211	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CASP3—malignant glioma	4.89e-05	0.000211	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FN1—malignant glioma	4.88e-05	0.000211	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—F2—malignant glioma	4.88e-05	0.000211	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTP1—malignant glioma	4.88e-05	0.000211	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2—malignant glioma	4.88e-05	0.000211	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FN1—malignant glioma	4.87e-05	0.00021	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—F2—malignant glioma	4.87e-05	0.00021	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—BAD—malignant glioma	4.83e-05	0.000209	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FN1—malignant glioma	4.82e-05	0.000208	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—F2—malignant glioma	4.82e-05	0.000208	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—BAD—malignant glioma	4.81e-05	0.000208	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	4.78e-05	0.000207	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	4.76e-05	0.000206	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—BAD—malignant glioma	4.76e-05	0.000206	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAT—malignant glioma	4.75e-05	0.000205	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—AKT1—malignant glioma	4.72e-05	0.000204	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	4.72e-05	0.000204	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CD80—malignant glioma	4.68e-05	0.000202	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CASP3—malignant glioma	4.68e-05	0.000202	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APC—malignant glioma	4.67e-05	0.000202	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	4.67e-05	0.000202	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2—malignant glioma	4.67e-05	0.000202	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CD80—malignant glioma	4.67e-05	0.000202	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APC—malignant glioma	4.66e-05	0.000201	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	4.66e-05	0.000201	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CD80—malignant glioma	4.62e-05	0.0002	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—EGF—malignant glioma	4.62e-05	0.0002	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP9—malignant glioma	4.62e-05	0.0002	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APC—malignant glioma	4.61e-05	0.000199	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	4.61e-05	0.000199	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTT1—malignant glioma	4.61e-05	0.000199	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—EGF—malignant glioma	4.61e-05	0.000199	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTPN11—malignant glioma	4.59e-05	0.000198	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PTEN—malignant glioma	4.59e-05	0.000198	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTPN11—malignant glioma	4.58e-05	0.000198	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—EGF—malignant glioma	4.56e-05	0.000197	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTPN11—malignant glioma	4.53e-05	0.000196	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NCOR1—malignant glioma	4.49e-05	0.000194	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—AKT1—malignant glioma	4.48e-05	0.000194	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP9—malignant glioma	4.42e-05	0.000191	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTEN—malignant glioma	4.4e-05	0.00019	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—BRAF—malignant glioma	4.39e-05	0.00019	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—BRAF—malignant glioma	4.38e-05	0.000189	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—BRAF—malignant glioma	4.34e-05	0.000187	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS1—malignant glioma	4.32e-05	0.000187	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—AKT1—malignant glioma	4.29e-05	0.000185	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AKT2—malignant glioma	4.28e-05	0.000185	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CB—malignant glioma	4.27e-05	0.000185	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AKT2—malignant glioma	4.26e-05	0.000184	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—EGFR—malignant glioma	4.26e-05	0.000184	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—EGFR—malignant glioma	4.24e-05	0.000183	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—malignant glioma	4.23e-05	0.000183	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AKT2—malignant glioma	4.22e-05	0.000182	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—EGFR—malignant glioma	4.2e-05	0.000182	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VEGFA—malignant glioma	4.15e-05	0.000179	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	4.11e-05	0.000178	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STAT3—malignant glioma	4.1e-05	0.000177	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	4.1e-05	0.000177	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	4.07e-05	0.000176	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	4.06e-05	0.000175	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	4.06e-05	0.000175	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—KRAS—malignant glioma	4.02e-05	0.000174	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	4.02e-05	0.000174	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—BCHE—malignant glioma	4.01e-05	0.000173	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—KRAS—malignant glioma	4.01e-05	0.000173	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—KRAS—malignant glioma	3.97e-05	0.000172	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VEGFA—malignant glioma	3.97e-05	0.000172	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.96e-05	0.000171	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FGF2—malignant glioma	3.93e-05	0.00017	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STAT3—malignant glioma	3.93e-05	0.00017	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FGF2—malignant glioma	3.92e-05	0.000169	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FGF2—malignant glioma	3.88e-05	0.000168	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MYC—malignant glioma	3.81e-05	0.000165	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—EGFR—malignant glioma	3.73e-05	0.000161	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	3.7e-05	0.00016	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTEN—malignant glioma	3.69e-05	0.000159	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	3.68e-05	0.000159	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MDM2—malignant glioma	3.68e-05	0.000159	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MDM2—malignant glioma	3.67e-05	0.000159	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RAF1—malignant glioma	3.67e-05	0.000159	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAV1—malignant glioma	3.66e-05	0.000158	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RAF1—malignant glioma	3.66e-05	0.000158	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MYC—malignant glioma	3.65e-05	0.000158	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	3.65e-05	0.000158	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MDM2—malignant glioma	3.63e-05	0.000157	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.63e-05	0.000157	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RAF1—malignant glioma	3.62e-05	0.000156	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ERBB2—malignant glioma	3.62e-05	0.000156	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ERBB2—malignant glioma	3.58e-05	0.000155	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.58e-05	0.000155	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—EGFR—malignant glioma	3.57e-05	0.000154	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	3.57e-05	0.000154	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	3.54e-05	0.000153	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—KRAS—malignant glioma	3.52e-05	0.000152	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.44e-05	0.000149	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL8—malignant glioma	3.43e-05	0.000148	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL8—malignant glioma	3.4e-05	0.000147	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—KRAS—malignant glioma	3.37e-05	0.000146	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.33e-05	0.000144	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3.32e-05	0.000144	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	3.31e-05	0.000143	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CASP3—malignant glioma	3.29e-05	0.000142	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2—malignant glioma	3.29e-05	0.000142	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CASP3—malignant glioma	3.28e-05	0.000142	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	3.28e-05	0.000142	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2—malignant glioma	3.28e-05	0.000142	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CASP3—malignant glioma	3.25e-05	0.000141	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2—malignant glioma	3.25e-05	0.00014	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	3.24e-05	0.00014	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARG—malignant glioma	3.22e-05	0.000139	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTP1—malignant glioma	3.19e-05	0.000138	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TP53—malignant glioma	3.13e-05	0.000135	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP9—malignant glioma	3.11e-05	0.000135	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAT—malignant glioma	3.11e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP9—malignant glioma	3.1e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	3.1e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTEN—malignant glioma	3.09e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTEN—malignant glioma	3.08e-05	0.000133	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP9—malignant glioma	3.07e-05	0.000133	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTEN—malignant glioma	3.05e-05	0.000132	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—AKT1—malignant glioma	3.02e-05	0.00013	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—AKT1—malignant glioma	3.01e-05	0.00013	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TP53—malignant glioma	3e-05	0.00013	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—AKT1—malignant glioma	2.98e-05	0.000129	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NCOR1—malignant glioma	2.93e-05	0.000127	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.93e-05	0.000127	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VEGFA—malignant glioma	2.8e-05	0.000121	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VEGFA—malignant glioma	2.79e-05	0.00012	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STAT3—malignant glioma	2.77e-05	0.00012	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VEGFA—malignant glioma	2.76e-05	0.000119	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STAT3—malignant glioma	2.76e-05	0.000119	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.73e-05	0.000118	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—AKT1—malignant glioma	2.64e-05	0.000114	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CA—malignant glioma	2.6e-05	0.000112	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MYC—malignant glioma	2.57e-05	0.000111	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MYC—malignant glioma	2.56e-05	0.000111	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.55e-05	0.00011	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MYC—malignant glioma	2.54e-05	0.00011	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—AKT1—malignant glioma	2.53e-05	0.000109	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—malignant glioma	2.53e-05	0.000109	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.52e-05	0.000109	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—EGFR—malignant glioma	2.51e-05	0.000108	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.48e-05	0.000107	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAV1—malignant glioma	2.39e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.38e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KRAS—malignant glioma	2.37e-05	0.000102	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.35e-05	0.000101	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTEN—malignant glioma	2.21e-05	9.53e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.18e-05	9.44e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.18e-05	9.41e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	2.18e-05	9.41e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	2.16e-05	9.31e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—AKT1—malignant glioma	2.13e-05	9.19e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TP53—malignant glioma	2.11e-05	9.13e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TP53—malignant glioma	2.11e-05	9.1e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARG—malignant glioma	2.1e-05	9.09e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TP53—malignant glioma	2.08e-05	9.01e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.91e-05	8.28e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.78e-05	7.71e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.78e-05	7.68e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.76e-05	7.61e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.67e-05	7.21e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—malignant glioma	1.65e-05	7.15e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.56e-05	6.73e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTEN—malignant glioma	1.44e-05	6.23e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AKT1—malignant glioma	1.27e-05	5.49e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.02e-05	4.4e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AKT1—malignant glioma	8.31e-06	3.59e-05	CbGpPWpGaD
